FDA Updates Dasatinib Label for Chronic Myeloid LeukemiaFDA Updates Dasatinib Label for Chronic Myeloid Leukemia
There are new safety and efficacy data for patients with Philadelphia-chromosome-positive chronic myeloid leukemia. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Health | Hematology | Leukemia